Determination of ximelagatran, melagatran and two intermediary metabolites in plasma by mixed-mode solid phase extraction and LC–MS/MS by Dunér, Kristina, Bäckström, Jonas, Magnell, Niklas, Svennberg, Henrik, Ahnoff, Martin, Logren, Ulrika

Get full text

Determination of ximelagatran, an oral direct thrombin inhibitor, its active metabolite melagatran, and the intermediate metabolites, in biological samples by liquid chromatography... by Larsson, Marita, Ahnoff, Martin, Abrahamsson, Anna, Logren, Ulrika, Fakt, Christina, Öhrman, Irene, Persson, Bengt-Arne

Get full text

Influence of age on the pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor by JOHANSSON, Linda C, FRISON, Lars, LOGREN, Ulrika, FAGER, Gunnar, GUSTAFSSON, David, ERIKSSON, Ulf G

Get full text

Biliary Excretion of Ximelagatran and Its Metabolites and the Influence of Erythromycin Following Intraintestinal Administration to Healthy Volunteers by Matsson, Elin M., Eriksson, Ulf G., Knutson, Lars, Hoffmann, Kurt-Jürgen, Logren, Ulrika, Fridblom, Patrik, Petri, Niclas, Lennernäs, Hans

Get full text

Determination of melagatran, a novel, direct thrombin inhibitor, in human plasma and urine by liquid chromatography–mass spectrometry by Larsson, Marita, Logren, Ulrika, Ahnoff, Martin, Lindmark, Bo, Abrahamsson, Peter, Svennberg, Henrik, Persson, Bengt-Arne

Get full text

Pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor ximelagatran co-administered with different classes of antibiotics in healthy volunteers by DORANI, Hassan, SCHIITZER, Kajs-Marie, SARICH, Troy C, WALL, Ulrika, LOGREN, Ulrika, OHLSSON, Lis, ERIKSSON, Ulf G

Get full text